23 results
idsa infections opportunistic diagnosis medications nephrology rheumatology cardiology differential mycobacterium algorithm antagonists antimuscarinic aviumcomplex behcets candida candidiasis capsulatum cardiomyopathy castlemans
Pharmacological Treatment of Hepatorenal Syndrome (HRS) Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Pharmacological Treatment ... of Hepatorenal Syndrome ... #Nephrology #Management ... #Pharmacology # ... Medications #Treatment
Muscarinic Receptor Agonists and Antagonists Muscarinic Receptor Agonists Methacholine • Diagnosis of bronchial airway Carbachol • Glaucorna (topical
neurogenic) • Urinary retention ... • Peptic ulcer disease ... • Parkinson disease ... #Medications #Pharmacology ... #Table
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
duration same as for treatment ... Note: Treatment ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Behcet's Syndrome - Treatment Ulcers: • Treatment: Topical steroids • Prevention: Colchicine • Azathioprine for refractory disease Arthritis:
Behcet's Syndrome ... : • Treatment: ... Topical steroids • Prevention ... #Syndrome #Treatment ... #management #pharmacology
Diuretics and Agents Regulating Renal Excretion Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide) • Glaucoma • Epilepsy • Altitude
irrigation • Management ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... #Pharmacology # ... Medications #Table
Summary of actions of some Cholinergic Agonists Bethanechol • Used in treatment of urinary retention • Binds
some Cholinergic Agonists ... for Alzheimer's disease ... #Cholinergic #Agonists ... #Pharmacology # ... Table #Summary
CNS Manifestations of Systemic Lupus Erythematosus (SLE) Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Demyelinating Syndrome ... Cerebrovascular Disease ... APS), Secondary prevention ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Recommendations for Preventing ... recommended for KS treatment ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary Epidemiology: • Prevalence: 1-2 cases per million -
Diagnosis and Management ... contractions (agonist ... Treatment: • ... SPS #Diagnosis #Management ... #treatment #neurology
No results found for "Management syndrome treatment pharmacology table neurology hivaids prevention disease agonists"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Management #syndrome #treatment #pharmacology #table #neurology #hivaids #prevention #disease #agonists